1. Home
  2. CTRN vs AGMB Comparison

CTRN vs AGMB Comparison

Compare CTRN & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citi Trends Inc.

CTRN

Citi Trends Inc.

SELL

Current Price

$43.76

Market Cap

559.1M

ML Signal

SELL

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

HOLD

Current Price

$6.00

Market Cap

576.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRN
AGMB
Founded
1946
2017
Country
United States
Belgium
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
559.1M
576.2M
IPO Year
2005
2024

Fundamental Metrics

Financial Performance
Metric
CTRN
AGMB
Price
$43.76
$6.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
★ $91.00
$37.67
AVG Volume (30 Days)
217.7K
★ 274.9K
Earning Date
12-01-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 112.14
N/A
EPS
★ 0.80
N/A
Revenue
★ $819,962,000.00
N/A
Revenue This Year
$10.94
N/A
Revenue Next Year
$8.69
N/A
P/E Ratio
$54.66
★ N/A
Revenue Growth
★ 8.88
N/A
52 Week Low
$36.05
$5.73
52 Week High
$77.91
$17.82

Technical Indicators

Market Signals
Indicator
CTRN
AGMB
Relative Strength Index (RSI) 41.29 26.49
Support Level $42.53 N/A
Resistance Level $52.14 $9.55
Average True Range (ATR) 3.52 0.85
MACD -0.31 -0.03
Stochastic Oscillator 8.50 10.36

Price Performance

Historical Comparison
CTRN
AGMB

About CTRN Citi Trends Inc.

Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: